Skip to main content
. 2019 Apr;31(2):357–365. doi: 10.21147/j.issn.1000-9604.2019.02.10

1.

1

Flowchart of severe dysplasia/carcinoma in situ (SD/CIS) patients in this population-based study. SD/CIS patients were divided into two groups by whether they received endoscopic treatments (EMR, MBM or ESD). EMR, endoscopic mucosal resection; MBM, multiband mucosectomy; ESD, endoscopic submucosal dissection; ESCC, esophageal squamous cell carcinoma.